167
Views
0
CrossRef citations to date
0
Altmetric
Cognition and Ageing

More than a third of middle-aged adults (50–65) have understated executive dysfunction

ORCID Icon, , , , , , , & show all
Pages 708-713 | Received 25 Oct 2021, Accepted 19 Feb 2022, Published online: 04 Mar 2022
 

Abstract

Objectives

Understated executive dysfunction (UED) is predictive of cognitive decline and death. We aimed to assess the prevalence of UED, assessed with the clock-drawing test (CDT) and the Frontal Assessment Battery (FAB) in middle-aged adults and to investigate associated characteristics.

Methods

Cross-sectional analysis of data on 516 community-dwellers aged 50-65, lacking cognitive complaints, who were included prospectively (2010-2017) after a multidimensional geriatric assessment at a “healthy ageing” outpatient clinic. Age- and educational-level-adjusted logistic models were used to assess factors associated with UED.

Results

The CDT and FAB were impaired in 27.7% and 14.7% of the participants (median age: 59.7 years). The prevalence [95% confidence interval (CI)] of UED was 36.2% [32.2-40.5%]. After adjustment for age and education, participants with UED were more likely to be obese (odds ratio [95%CI] = 1.89 [1.12-3.19], P = 0.02), and to have a metabolic syndrome (1.98 [1.06-3.72], P = 0.03).

Conclusion

More than one third of middle-aged adults without cognitive complaints have UED, which was linked to obesity and metabolic syndrome. Cognitive screening tests targeting executive functions might be useful for early detection of UED and the initiation of multidomain interventions improving cognitive performance.

Acknowledgements

The authors thank David Fraser (Biotech Communication SARL, Ploudalmézeau, France) for editorial assistance. All authors read and approved the final version.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Funding

The author(s) reported there is no funding associated with the work featured in this article.

Data Availability

The datasets analyzed during the current study are not publicly available because they are the property of Assistance Publique Hôpitaux de Paris. Any individual may apply for data by contacting the Direction de la Recherche Clinique et de l’Innovation (DRCI) at [email protected].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.